Sanofi Accelerates Its ‘Carbon Neutral’ Pledge Ahead Of Climate Summit
Sets 2030 Carbon Neutrality Goal
Executive Summary
The France-headquartered company has brought forward its carbon neutral goal, making it one of the sector’s most proactive companies.
You may also be interested in...
Dupixent Keeps Sanofi At Forefront Of European Pharma Growth
Sanofi is on a roll thanks to Dupixent and the blockbuster is providing breathing space even when some key pipeline assets are delayed.
Vertex Spots Potential Bargain Of $60m Entry Into Complement Regulation
Vertex has acquired the full assets to a promising protease-based drug platform from Catalyst, broadening its R&D base once again.
Zymeworks Rejects ‘Opportunistic’ Investor Takeover Bid
Activist investor All Blue wants to mount a takeover, but the biotech’s board is holding out for encouraging pipeline news to help fight off the bid.